Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23052783 | 0.76 | TSHR (0.32) | — | |
| SCHEMBL453463 | 0.74 | — | — | |
| SCHEMBL10207220 | 0.73 | TSHR (0.39) | — | |
| SCHEMBL20999124 | 0.73 | TSHR (0.39) | — | |
| SCHEMBL22487748 | 0.73 | TSHR (0.39) | — | |
| SCHEMBL31234108 | 0.73 | ALDH1A1 (0.31) | — | |
| SCHEMBL10547847 | 0.72 | ALDH1A1 (0.36) | FFAR3 | |
| SCHEMBL28436624 | 0.72 | ALDH1A1 (0.47) | FFAR3 | |
| SCHEMBL28436622 | 0.72 | ALDH1A1 (0.47) | FFAR3 | |
| Hydrochloric Acid SCHEMBL28906443 | 0.71 | TSHR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3943083-A1 | SMALL-MOLECULE INHIBITOR OF PD-1/PD-L1, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND APPLICATION OF SAME | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. (CN) | 2022-01-26 | — | — | EP | disclosed |
| EP-3733659-A1 | AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. (CN) | 2020-11-04 | — | — | EP | disclosed |
| WO-2020192570-A1 | SMALL-MOLECULE INHIBITOR OF PD-1/PD-L1, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND APPLICATION OF SAME | 上海再极医药科技有限公司 | 2020-10-01 | — | — | WO | disclosed |